chr7-138798120-G-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001085429.2(TMEM213):c.16G>T(p.Ala6Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000625 in 1,600,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001085429.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM213 | NM_001085429.2 | c.16G>T | p.Ala6Ser | missense_variant | 1/3 | ENST00000442682.7 | NP_001078898.1 | |
ATP6V0A4 | NM_020632.3 | c.-207C>A | 5_prime_UTR_variant | 1/22 | ENST00000310018.7 | NP_065683.2 | ||
ATP6V0A4 | NM_130840.3 | c.-104C>A | 5_prime_UTR_variant | 1/21 | NP_570855.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM213 | ENST00000442682.7 | c.16G>T | p.Ala6Ser | missense_variant | 1/3 | 1 | NM_001085429.2 | ENSP00000390407 | P4 | |
ATP6V0A4 | ENST00000310018.7 | c.-207C>A | 5_prime_UTR_variant | 1/22 | 1 | NM_020632.3 | ENSP00000308122 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152096Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000891 AC: 2AN: 224516Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 121762
GnomAD4 exome AF: 0.00000553 AC: 8AN: 1447958Hom.: 0 Cov.: 31 AF XY: 0.00000278 AC XY: 2AN XY: 718852
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152096Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 74294
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 29, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at